{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:55:54Z","timestamp":1790081754104,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T00:00:00Z","timestamp":1563062400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25DA033270"],"award-info":[{"award-number":["R25DA033270"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DA013429"],"award-info":[{"award-number":["P30 DA013429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.neuroscience.2018.06.029","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:11:19Z","timestamp":1530126679000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians"],"prefix":"10.1016","volume":"386","author":[{"given":"Emily","family":"Dziedowiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil U.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan S.","family":"Gruver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyra","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2018.06.029_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130100793","article-title":"Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test","volume":"157","author":"Anraku","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(90)90153-W","article-title":"Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat","volume":"175","author":"Bals-Kubik","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0091-3057(81)90403-2","article-title":"Locomotor activity in morphine-dependent and post-dependent rats","volume":"14","author":"Brady","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0025","first-page":"225","article-title":"Acetylcholine\/dopamine interaction in planaria","volume":"125","author":"Buttarelli","year":"2000","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/PL00004988","article-title":"Conditioned place preference: no tolerance to the rewarding properties of morphine","volume":"355","author":"Contarino","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1068\/p6949","article-title":"Shedding light on photosensitive behaviour in brown planaria (Dugesia Tigrina)","volume":"40","author":"Davidson","year":"2011","journal-title":"Perception"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature25473","article-title":"The genome of Schmidtea mediterranea and the evolution of core cellular mechanisms","volume":"554","author":"Grohme","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2015.03.021","article-title":"Persistent conditioned place preference to cocaine and withdrawal hypo-locomotion to mephedrone in the flatworm planaria","volume":"593","author":"Hutchinson","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0050","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00213-014-3695-y","article-title":"Morphine-induced conditioned place preference and effects of morphine pre-exposure in adolescent and adult male C57BL\/6J mice","volume":"233","author":"Koek","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0055","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0060","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/00001756-200008030-00033","article-title":"Reinforcing effects of methamphetamine in planarians","volume":"11","author":"Kusayama","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3565(25)24375-0","article-title":"Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats","volume":"238","author":"Locke","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-3391-9-2","article-title":"Fine-scale differences in diel activity among nocturnal freshwater planarias (Platyhelminthes: Tricladida)","volume":"9","author":"Lombardo","year":"2011","journal-title":"J Circadian Rhythms"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0143-4179(89)90076-0","article-title":"MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice","volume":"13","author":"Michael-Titus","year":"1989","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02244050","article-title":"Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL\/6J mouse","volume":"101","author":"Mickley","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0085","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1471-4159.2001.00599.x","article-title":"A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice","volume":"79","author":"Murphy","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0090","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/09553002.2014.911421","article-title":"Comparisons of responses by planarian to micromolar to attomolar dosages of morphine or naloxone and\/or weak pulsed magnetic fields: revealing receptor subtype affinities and non-specific effects","volume":"90","author":"Murugan","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/FBP.0000000000000236","article-title":"Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians","volume":"27","author":"Nayak","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pbb.2013.06.010","article-title":"Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice","volume":"110","author":"Niikura","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2010.03.038","article-title":"Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica","volume":"168","author":"Nishimura","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pbb.2007.12.008","article-title":"Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones","volume":"89","author":"Pag\u00e1n","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2009.05.022","article-title":"A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms","volume":"615","author":"Pag\u00e1n","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0120","series-title":"The First Brain: The Neuroscience of Planarians","author":"Pag\u00e1n","year":"2014"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008877-200211000-00001","article-title":"Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine","volume":"13","author":"Paine","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0742-8413(96)00053-9","article-title":"A pharmacological study of cocaine activity in planaria","volume":"115","author":"Palladini","year":"1996","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0742-8413(99)00048-1","article-title":"Opioid-dopamine interaction in planaria: a behavioral study","volume":"124","author":"Passarelli","year":"1999","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2013.09.012","article-title":"Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model","volume":"112","author":"Raffa","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2007.12.001","article-title":"The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212\u20132), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'","volume":"1193","author":"Raffa","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01358-9","article-title":"Cocaine withdrawal in Planaria","volume":"430","author":"Raffa","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0155","series-title":"A model for drug action and abuse","author":"Raffa","year":"2008"},{"issue":"3","key":"10.1016\/j.neuroscience.2018.06.029_b9000","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00814-0","article-title":"kappa-Opioid withdrawal in Planaria","volume":"349","author":"Raffa","year":"2003","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.neuroscience.2018.06.029_b0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2012.01.019","article-title":"Mephedrone (\u201cbath salt\u201d) pharmacology: insights from invertebrates","volume":"208","author":"Ramoz","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.npep.2008.03.005","article-title":"Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians","volume":"42","author":"Rawls","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejphar.2008.02.018","article-title":"The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians","volume":"584","author":"Rawls","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pbb.2007.01.010","article-title":"An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)","volume":"86","author":"Rawls","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2011.04.001","article-title":"Nicotine behavioral pharmacology: clues from planarians","volume":"118","author":"Rawls","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2006.04.103","article-title":"A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria","volume":"1099","author":"Rawls","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0190","first-page":"209","article-title":"[3H]naloxone as an opioid receptor label: analysis of binding site heterogeneity and use for determination of opioid affinities of casomorphin analogues","volume":"49","author":"Schnittler","year":"1990","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2013.12.004","article-title":"Dopamine is differentially involved in the locomotor hyperactivity produced by manipulations of opioid, GABA and glutamate receptors in the median raphe nucleus","volume":"261","author":"Shim","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0200","first-page":"563","article-title":"Differential effects of mu and kappa opioid systems on motivational processes","volume":"75","author":"Shippenberg","year":"1986","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(91)90774-K","article-title":"Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference","volume":"205","author":"Suzuki","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.alcohol.2014.07.006","article-title":"Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians","volume":"48","author":"Tallarida","year":"2014","journal-title":"Alcohol"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00213-003-1626-4","article-title":"Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","volume":"172","author":"Tzschentke","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vascn.2004.07.002","article-title":"A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria","volume":"51","author":"Umeda","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(87)90178-8","article-title":"Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens","volume":"417","author":"Vezina","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00958970701220416","article-title":"Estradiol decreases anxiety behavior and enhances inhibitory avoidance and gestational stress produces opposite effects","volume":"10","author":"Walf","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0235","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.neuroscience.2009.06.068","article-title":"Social and physical environment alter cocaine conditioned place preference and dopaminergic markers in adolescent male rats","volume":"163","author":"Zakharova","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jneumeth.2017.10.010","article-title":"PLDT (planarian light\/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects","volume":"293","author":"Zewde","year":"2018","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0245","first-page":"8","article-title":"Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians","volume":"112\u2013113","author":"Zhang","year":"2013","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2018.06.029_b0250","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/jpet.103.054775","article-title":"Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors","volume":"307","author":"Zhao","year":"2003","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218304408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218304408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:47:08Z","timestamp":1759679228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218304408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"alternative-id":["S0306452218304408"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.06.029","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}